Early events in Epstein-Barr virus infection provide a model for B cell activation
- PMID: 2989413
- PMCID: PMC2187697
- DOI: 10.1084/jem.162.1.45
Early events in Epstein-Barr virus infection provide a model for B cell activation
Abstract
We have used Epstein-Barr virus (EBV) infection in vitro to delineate two distinct stages in B cell activation. Previous studies have shown that the BLAST-2 (EBVCS) (EBV cell surface) activation antigen is expressed on a small fraction of B cells within 24 h of stimulation with a variety of agents, including mitogens and EBV. In this study, we have been able to isolate the BLAST-2 (EBVCS)+ cells early after activation/infection with EBV. These cells are small B cells that are actively synthesizing RNA but not DNA, and are, therefore, clearly distinct from large proliferating lymphoblasts. In addition, they contain multiple copies of the EBV genome, express the viral nuclear antigen (EBNA) and, most importantly, proceed to undergo transformation when placed back in culture. By comparison, the BLAST-2 (EBVCS)- population does not undergo transformation, even though a fraction of these cells are activated for RNA synthesis and express EBNA. Thus, using the EBV system, we have been able to show directly that an activated B cell first expresses the BLAST-2 (EBVCS) antigen concomitant with an increase in RNA synthesis, and then subsequently proceeds to differentiate into a proliferating lymphoblast.
Similar articles
-
BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.J Immunol. 1985 May;134(5):3007-12. J Immunol. 1985. PMID: 2984280
-
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6. doi: 10.1073/pnas.84.10.3452. Proc Natl Acad Sci U S A. 1987. PMID: 3033649 Free PMC article.
-
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62. doi: 10.1073/pnas.86.23.9558. Proc Natl Acad Sci U S A. 1989. PMID: 2556717 Free PMC article.
-
Epstein-Barr virus: exploiting the immune system.Nat Rev Immunol. 2001 Oct;1(1):75-82. doi: 10.1038/35095584. Nat Rev Immunol. 2001. PMID: 11905817 Review.
-
Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Eur J Cell Biol. 2012. PMID: 21450364 Review.
Cited by
-
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.J Virol. 1989 Oct;63(10):4121-8. doi: 10.1128/JVI.63.10.4121-4128.1989. J Virol. 1989. PMID: 2550660 Free PMC article.
-
Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP.J Virol. 1990 Feb;64(2):829-37. doi: 10.1128/JVI.64.2.829-837.1990. J Virol. 1990. PMID: 2153246 Free PMC article.
-
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.Cell Metab. 2019 Sep 3;30(3):539-555.e11. doi: 10.1016/j.cmet.2019.06.003. Epub 2019 Jun 27. Cell Metab. 2019. PMID: 31257153 Free PMC article.
-
Epstein-barr virus, the immune system, and associated diseases.Front Microbiol. 2011 Jan 26;2:5. doi: 10.3389/fmicb.2011.00005. eCollection 2011. Front Microbiol. 2011. PMID: 21687403 Free PMC article.
-
Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.J Virol. 1994 Oct;68(10):6421-31. doi: 10.1128/JVI.68.10.6421-6431.1994. J Virol. 1994. PMID: 8083980 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials